210
Participants
Start Date
May 31, 2007
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Medtronic Cardiac Ablation System
Arm 1 (Ablation Management): Ablation procedures using investigational catheters in left atrium. Cardioversion could be used to restore sinus rhythm if needed.
Class I or III Antiarrhythmic Medications
Arm 2 (Medical Management): Class I or III antiarrhythmic drugs. Changes in dosing, antiarrhythmic drugs or combinations of antiarrhythmic drugs were allowed. Direct current cardioversions were also allowed at the discretion of the investigator.
University of Rochester, Rochester
Consultants in Cardiovascular Diseases, Erie
Washington Adventist Hospital, Takoma Park
Johns Hopkins Hospital, Baltimore
Sentara Cardiovascular Research Institute, Norfolk
Wake Forest University, Winston-Salem
Emory Crawford Long Hospital, Atlanta
Piedmont Hospital, Atlanta
Mayo Clinic Jacksonville, Jacksonville
The Ohio State University, Columbus
Krannert Institute of Cardiology, Indianapolis
University of Michigan, Ann Arbor
Spectrum Health Research Department, Grand Rapids
Iowa Heart Center, Des Moines
Genesis Medical Center, Davenport
University of Chicago, Chicago
Texas Heart Institute at St. Luke's Episcopal, Houston
Austin Heart, Austin
Arizona Arrhythmia Research Center, Scottsdale
UCLA Cardiac Arrhythmia Center, Los Angeles
Massachusetts General Hospital Cardiac Arrhythmia, Boston
Brigham and Women's Hospital, Boston
Lahey Clinic, Burlington
St. Antonius Ziekenhuis, Nieuwegein
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY